Dendritic Cell-Based Vaccines in Cancer: Clinical Experience to Date

By Morse M.A.   Mosca P.J.   Clay T.M.   Lyerly H.K.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 313-322

Adis International

Access to resources Recommend Favorite

Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

By Kalinski Pawel   Urban Julie   Narang Rahul   Berk Erik   Wieckowski Ewa   Muthuswamy Ravikumar  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 379-390

Future Medicine

Access to resources Recommend Favorite

Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines

By Ruben Jurjen   Ancker Willemijn   Bontkes Hetty   Westers Theresia   Hooijberg Erik   Ossenkoppele Gert   Gruijl Tanja   Loosdrecht Arjan  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

By Palma M.   Adamson L.   Hansson L.   Kokhaei P.   Rezvany R.   Mellstedt H.   Österborg A.   Choudhury A.  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1705-1710

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma

By Waeckerle-Men Ying   Uetz-von Allmen Edith   Fopp Markus   Moos Roger   Böhme Christel   Schmid Hans-Peter   Ackermann Daniel   Cerny Thomas   Ludewig Burkhard   Groettrup Marcus   Gillessen Silke  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1524-1533

Springer Publishing Company

Access to resources Recommend Favorite